Why Walgreen is Staying American and Paying Its Taxes

Walgreens buys Switzerland-based Alliance Boots, but decides not to move overseas in the process.

Aug 10, 2014 at 7:03AM
Walgreens

Source: Walgreens

Walgreen (NASDAQ:WBA) announced this week that it plans to buy the 55% of Switzerland-based Alliance Boots that it doesn't already own, but the American pharmacy isn't going to move overseas to lower its taxes as Wall Street had expected.

Investors are none too happy, sending shares down 14% on Wednesday.

Walgreen blamed the decision on an inability to structure a transaction with Alliance Boots that would allow it to move overseas. To undergo these so-called tax inversions, companies have to follow strict rules such as a certain percentage of the shareholders of the new company have to come from the foreign company. Management was clearly concerned with a protracted fight with the IRS.

But Walgreen hinted that the decision to stay in the U.S. was influenced by the potential for its business to suffer if it moved overseas.

"The company also was mindful of the ongoing public reaction to a potential inversion and Walgreen's unique role as an iconic American consumer retail company with a major portion of its revenues derived from government-funded reimbursement programs."

While you could certainly see a bit of an uproar if Walgreen moved overseas, I have a hard time seeing customers leaving for the long-term.

How many people avoid drinking Budweiser because it's no longer American? How about eating a Good Humor ice cream bar? Shopping at 7-Eleven? Feeding your baby Gerber-brand pureed carrots?

They're all owned by companies headquartered outside the U.S. Even John Hancock Life Insurance -- named after the guy who first signed the U.S. Declaration of Independence -- isn't even owned by a U.S. company .

Admittedly there's a difference between brands being bought by a foreign company and purposely moving overseas to avoid taxes. Maybe the bad press would have put a dent in business, especially when competitors, such as CVS Caremark (NYSE: CVS) are getting good press with its decision to stop selling cigarettes and tobacco products in its stores.

Government strikes back
While tax inversions are perfectly legal if all the rules are followed, President Obama isn't pleased that companies are moving overseas. Last month, Treasury Secretary Jacob J. Lew sent a letter to members of Congress urging them to "support legislative initiatives to reverse the trend toward corporate inversions."

With a divided congress and midterm elections approaching, passing that kind of legislation doesn't seem particularly likely.

Rather than push to stop tax inversions, the government could just discourage companies from moving overseas by not doing business with them. As Walgreen points out, "government-funded reimbursement programs" -- Medicare and Medicaid, for instance -- are a major portion of its business. If it wasn't allowed to participate in those programs the company would be sunk.

But it's hard to see how that type of legislation might be enacted given that there are plenty of foreign companies that provide useful services to Medicare and Medicaid. The largest generic-drug makers, Teva Pharmaceuticals (NYSE:TEVA), Novartis' (NYSE:NVS) Sandoz, and soon-to-be Mylan (NASDAQ:MYL), are all headquartered overseas. It's hard to see how the government could avoid doing business with them.

Perhaps the law could be structured to only include companies that have moved after a certain date. But even that runs into ethical issues. Imagine if a drug company with the only treatment available for a certain disease does a tax inversion. Is the government going to deny citizens the drug because it's not paying U.S. tax?

Chickened out
In the end, it seems Walgreen just decided the risks -- legality of the transaction, potential IRS troubles, damage to reputation, and political backlash -- didn't justify the reward of lower taxes. Management arguably chickened out, but being conservative isn't necessarily the worst trait to have in management.

Walgreen looks like a decent investment at this knocked down price, with a solid 1.7% dividend yield and some global growth prospects as it integrates Alliance Boots.

Even if it'll be paying a little more taxes than it could have.

Speaking of dividends
The smartest investors know that dividend stocks simply crush their non-dividend paying counterparts over the long term. That's beyond dispute. They also know that a well-constructed dividend portfolio creates wealth steadily, while still allowing you to sleep like a baby. Knowing how valuable such a portfolio might be, our top analysts put together a report on a group of high-yielding stocks that should be in any income investor's portfolio. To see our free report on these stocks, just click here now.

Brian Orelli has no position in any stocks mentioned. The Motley Fool recommends Teva Pharmaceutical Industries. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

1 Key Step to Get Rich

Our mission at The Motley Fool is to help the world invest better. Whether that’s helping people overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we can help.

Feb 1, 2016 at 4:54PM

To be perfectly clear, this is not a get-rich action that my Foolish colleagues and I came up with. But we wouldn't argue with the approach.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich" rated The Motley Fool as the #1 place online to get smarter about investing.

"The Motley Fool aims to build a strong investment community, which it does by providing a variety of resources: the website, books, a newspaper column, a radio [show], and [newsletters]," wrote (the clearly insightful and talented) money reporter Kathleen Elkins. "This site has something for every type of investor, from basic lessons for beginners to investing commentary on mutual funds, stock sectors, and value for the more advanced."

Our mission at The Motley Fool is to help the world invest better, so it's nice to receive that kind of recognition. It lets us know we're doing our job.

Whether that's helping the entirely uninitiated overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we want to provide our readers with a boost to the next step on their journey to financial independence.

Articles and beyond

As Business Insider wrote, there are a number of resources available from the Fool for investors of all levels and styles.

In addition to the dozens of free articles we publish every day on our website, I want to highlight two must-see spots in your tour of fool.com.

For the beginning investor

Investing can seem like a Big Deal to those who have yet to buy their first stock. Many investment professionals try to infuse the conversation with jargon in order to deter individual investors from tackling it on their own (and to justify their often sky-high fees).

But the individual investor can beat the market. The real secret to investing is that it doesn't take tons of money, endless hours, or super-secret formulas that only experts possess.

That's why we created a best-selling guide that walks investors-to-be through everything they need to know to get started. And because we're so dedicated to our mission, we've made that available for free.

If you're just starting out (or want to help out someone who is), go to www.fool.com/beginners, drop in your email address, and you'll be able to instantly access the quick-read guide ... for free.

For the listener

Whether it's on the stationary exercise bike or during my daily commute, I spend a lot of time going nowhere. But I've found a way to make that time benefit me.

The Motley Fool offers five podcasts that I refer to as "binge-worthy financial information."

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. It's also featured on several dozen radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable ... and I don't say that simply because the hosts all sit within a Nerf-gun shot of my desk. Rule Breaker Investing and Answers contain timeless advice, so you might want to go back to the beginning with those. The other three take their cues from the market, so you'll want to listen to the most recent first. All are available at www.fool.com/podcasts.

But wait, there's more

The book and the podcasts – both free ... both awesome – also come with an ongoing benefit. If you download the book, or if you enter your email address in the magical box at the podcasts page, you'll get ongoing market coverage sent straight to your inbox.

Investor Insights is valuable and enjoyable coverage of everything from macroeconomic events to investing strategies to our analyst's travels around the world to find the next big thing. Also free.

Get the book. Listen to a podcast. Sign up for Investor Insights. I'm not saying that any of those things will make you rich ... but Business Insider seems to think so.


Compare Brokers